Discover the complete record of transactions filed by 이동철, Chairman & CEO. Director active across 3 companies, notably 명인제약. In total, 17,943 filings have been logged. Activity tracked since 4 March 2026. The latest transaction was filed on 4 March 2026 (Purchase). Regulator: DART (FSS). The full history is free.
Lee Dong-cheol is the chairman and CEO of Myungin Pharmaceutical. He oversees all operations of the company and is responsible for defining growth strategies. His leadership is essential for guiding Myungin Pharmaceutical towards innovation and excellence in the pharmaceutical sector.